Scientists hunt for early warning signs of chemotherapy heart damage
NCT ID NCT01173341
Summary
This study aims to find early warning signs that predict heart damage in breast cancer patients receiving certain chemotherapy drugs. Researchers will follow 700 patients for up to 10 years, tracking blood markers and heart scans to identify who is most at risk. The goal is to help doctors detect heart problems earlier and potentially prevent serious complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.